PREPAiRE IS AN ECOSYSTEM
AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of the existing molecule, intelligent clinical design, and coupled with in-house manufacturing.
PREPAiRE purposely integrates target identification, validation, lead discovery, optimization, drug synthesis, and preclinical testing into a single platform.
Many of the bottlenecks in drug discovery and development could be alleviated if only we could predict earlier in the disease process which drugs are likely to work and for which patients. At PREPAiRE, we enable better predictions throughout the pharmaceutical value chain in a single platform.
PREPAiRE purposely integrates target identification, validation, lead discovery, optimization, drug synthesis, and preclinical testing into a single platform.
Many of the bottlenecks in drug discovery and development could be alleviated if only we could predict earlier in the disease process which drugs are likely to work and for which patients. At PREPAiRE, we enable better predictions throughout the pharmaceutical value chain in a single platform.
Our founding vision
Our platform accelerates the drug development by integrating disease models spanning in-vitro cellular systems, in-silico machine learning models, and insitro models.
These models, combined with robotic chemical systems capable of navigating a chemical space based on learned general associations between molecular structures and reactivity, it is possible to identify a range of chemical reactions and products that ultimately lead to the discovery of new molecules that can eventually become new specialty treatments.
The founding vision of PREPAiRE — is that it is possible to integrate target identification and validation, lead discovery and optimization, drug synthesis, and pre-clinical testing into a single platform.
AI fundamental ethics
At PREPAiRE, we are proud of our participation in pushing forward the science of drug development. We believe AI can be of extraordinary benefit to the world, but only if held to the highest ethical standards.
_________________________
Technology is not valued neutral, and technologists must take responsibility for their work's ethical and social impact.
_________________________
As history attests, technological innovation is no guarantee of broader social progress. The development of AI creates important and complex questions. Its impact on society—and all our lives—is not something that should be left to chance. Beneficial outcomes and protections against harm must be actively fought for and built in from the beginning.
At PREPAiRE, we are proud of our participation in pushing forward the science of drug development. We believe AI can be of extraordinary benefit to the world, but only if held to the highest ethical standards.
_________________________
Technology is not valued neutral, and technologists must take responsibility for their work's ethical and social impact.
_________________________
As history attests, technological innovation is no guarantee of broader social progress. The development of AI creates important and complex questions. Its impact on society—and all our lives—is not something that should be left to chance. Beneficial outcomes and protections against harm must be actively fought for and built in from the beginning.
Inclusive Research
& Design
& Design
At PREPAiRE, equity and inclusion are core values that we seek to promote among our Partner organizations, in our work, and throughout the greater AI field, including in machine learning and other automated decision-making systems.
The PREPARE Partner Program is currently creating resources to help R&D and Pharmaceutical companies more effectively engage one another to develop drugs responsibly. Ultimately, this work seeks to achieve a more holistic reimagining of how drugs are developed and deployed worldwide.
The PREPARE Partner Program is currently creating resources to help R&D and Pharmaceutical companies more effectively engage one another to develop drugs responsibly. Ultimately, this work seeks to achieve a more holistic reimagining of how drugs are developed and deployed worldwide.
Explore Our Features
Our AI expertise extends beyond our ranks. Collaborations with top universities, start-ups, and established technology companies boost PREPAiRE’s ability to meet social and market needs.
No single organization can master all. It is too big. It is a worldwide ecosystem of brilliant minds and spectacular tools scattered through tens of thousands of companies and universities.
Progressive Scientific Collaboration
We collaborate with Stanford, MIT, and the University of Cambridge. Our Alliances with Nvidia, Google, and Microsoft Azure enable us to run models at scale.
PREPAiRE has identified the leading minds and forged relationships to strengthen our strategy-through-execution capabilities. We continuously monitor emerging technology players. Amid the countless vendors and startups, we have identified those with market-leading solutions and the capacity to deliver. We are forging strategic relationships with leading innovators and companies.
Partnering with PREPAiRE
By joining forces with like-minded experts from across the industry, academia, and the nonprofit sector, we are better equipped to lead the way towards transforming drug discovery and development through machine learning.
If you would like to learn more about partnering with us, please reach out to partners@prepaire.com
If you would like to learn more about partnering with us, please reach out to partners@prepaire.com